UNSPSC 51111861: Terfluranol

This classification denotes an antineoplastic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WUF1DL156G. European Medicines Agency schedules Terfluranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10922MIG. Terfluranol generally arises in the molecular formula C17H17F3O2.

UNSPSC 51111861 Terfluranol is a Commodity code covering generic pharmaceutical products supplied through state and local cooperative purchasing arrangements. State and local governments procure generic multi-source pharmaceuticals and over-the-counter products under this code through multistate cooperative agreements that standardize pricing, product specifications, and distribution channels to licensed wholesalers serving state agencies, counties, cities, and institutional facilities across participating jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions. Vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). Pricing evaluation is weighted heavily on price competitiveness (75 percent), with secondary criteria including fixed pricing for contract term (10 percent), price format options such as flat price, net price, or WAC-minus structures (5 percent), EDI capability (5 percent), and administrative fee compliance (5 percent). The contract term runs two years for new vendors with optional extensions, while incumbent amendments align through June 30, 2028. Products must be available in the marketplace by May 15, 2026, with effective dates of July 1, 2026, and vendors must maintain comprehensive insurance coverage including $5,000,000 commercial general liability and $2,000,000 network security and privacy liability.